RESUMO
BACKGROUND: Schmallenberg virus (SBV) is an emerging Orthobunyavirus of ruminant livestock species currently circulating in Europe. SBV causes a subclinical or mild disease in adult animals but vertical transmission to pregnant dams may lead to severe malformations in the offspring. Data on the onset of clinical signs, viremia and seroconversion in experimentally infected adult animals are available for cattle and sheep but are still lacking for goats. For a better understanding of the pathogenesis of SBV infection in adult ruminants, we carried out experimental infections in adult goats. Our specific objectives were: (i) to record clinical signs, viremia and seroconversion; (ii) to monitor viral excretion in the semen of infected bucks; (iii) to determine in which tissues SBV replication took place and virus-induced lesions developed. RESULTS: Four goats and two bucks were inoculated with SBV. Virus inoculation was followed by a short viremic phase lasting 3 to 4 days and a seroconversion occurring between days 7 and 14 pi in all animals. The inoculated goats did not display any clinical signs, gross lesions or histological lesions. Viral genomic RNA was found in one ovary but could not be detected in other organs. SBV RNA was not found in the semen samples collected from two inoculated bucks. CONCLUSIONS: In the four goats and two bucks, the kinetics of viremia and seroconversion appeared similar to those previously described for sheep and cattle. Our limited set of data provides no evidence of viral excretion in buck semen.
Assuntos
Infecções por Bunyaviridae/veterinária , Doenças das Cabras/virologia , Orthobunyavirus/isolamento & purificação , Animais , Infecções por Bunyaviridae/epidemiologia , Infecções por Bunyaviridae/virologia , Ensaio de Imunoadsorção Enzimática , Cabras , Masculino , RNA Viral/sangue , RNA Viral/isolamento & purificação , Reação em Cadeia da Polimerase em Tempo Real/veterináriaRESUMO
Bluetongue virus (BTV) and Epizootic haemorrhagic disease virus (EHDV) are closely related Orbiviruses that affect domestic and wild ruminants. In Ecuador previous serological studies reported the presence of BTV; however, no data are available about the presence of EHDV. In this study, 295 cattle without symptoms of infection were sampled from two farms located in Andean and Amazonian regions and from a slaughterhouse in the coastal region. ELISA analyses showed high prevalence of BTV (98.9%) and EHDV (81.3%) antibodies, and RT-qPCRs revealed the presence of EHDV (24.1%) and BTV (10.2%) genomes in cattle blood samples. Viral isolation allowed to identify EHDV serotype 1 (EHDV1) and BTV serotypes 9 (BTV9), 13 and 18. These findings suggest that BTV and EHDV are enzootic diseases in Ecuador.
Assuntos
Vírus Bluetongue/isolamento & purificação , Bluetongue/virologia , Doenças dos Bovinos/virologia , Vírus da Doença Hemorrágica Epizoótica/isolamento & purificação , Infecções por Reoviridae/veterinária , Sorogrupo , Animais , Anticorpos Antivirais/sangue , Bluetongue/epidemiologia , Vírus Bluetongue/genética , Vírus Bluetongue/imunologia , Bovinos , Doenças dos Bovinos/epidemiologia , Equador/epidemiologia , Ensaio de Imunoadsorção Enzimática/veterinária , Vírus da Doença Hemorrágica Epizoótica/genética , Vírus da Doença Hemorrágica Epizoótica/imunologia , Reação em Cadeia da Polimerase em Tempo Real/veterinária , Infecções por Reoviridae/epidemiologia , Infecções por Reoviridae/virologia , Estudos Soroepidemiológicos , Sorotipagem , América do Sul/epidemiologiaRESUMO
In 2014, a new bluetongue virus serotype 4 (BTV-4) strain was detected in southern Greece and spread rapidly throughout the Balkan Peninsula and adjacent countries. Within half a year, more than 7,068 outbreaks were reported in ruminants, particularly in sheep. However, the reported morbidity and case fatality rates in ruminants varied. The pathogenesis of a Bulgarian BTV-4 strain isolated from sheep during the BTV-4 epizootic was studied in different species. Therefore, four sheep, three goats and three cattle were experimentally infected with the isolate BTV-4/BUL2014/15 and monitored for clinical signs up to several weeks. Serum and whole-blood samples were collected at regular intervals and subjected to serological and virological analyses. In this context, BTV-4-specific real-time RT-PCR assays were developed. The infection kinetics were similar to those known for other traditional BTV serotypes, and only mild BT-like clinical signs were observed in goats and sheep. In cattle, no obvious clinical signs were observed, except a transient increase in body temperature. The study results contrast with the severe clinical signs reported in sheep experimentally infected with an African BTV-4 strain and with the reports of BT-like clinical signs in a considerable proportion of different ruminant species infected with BTV-4 in the Balkan region and Italy. The discrepancies between the results of these animal trials and observations of BTV-4 infection in the field may be explained by the influence of various factors on the manifestation of BT disease, such as animal breed, fitness and virus strain, as described previously.
Assuntos
Vírus Bluetongue/patogenicidade , Bluetongue/virologia , Doenças dos Bovinos/virologia , Surtos de Doenças/veterinária , Doenças das Cabras/virologia , Animais , Bluetongue/epidemiologia , Vírus Bluetongue/imunologia , Vírus Bluetongue/isolamento & purificação , Bulgária/epidemiologia , Bovinos , Doenças dos Bovinos/epidemiologia , Doenças das Cabras/epidemiologia , Cabras , Masculino , Reação em Cadeia da Polimerase em Tempo Real/veterinária , Sorogrupo , OvinosRESUMO
In November 2016, sheep located in the south of Corsica island exhibited clinical signs suggestive of bluetongue virus (BTV) infection. Laboratory analyses allowed to isolate and identify a BTV strain of serotype 4. The analysis of the full viral genome showed that all the 10 genomic segments were closely related to those of the BTV-4 present in Hungary in 2014 and involved in a large BT outbreak in the Balkan Peninsula. These results together with epidemiological data suggest that BTV-4 has been introduced to Corsica from Italy (Sardinia) where BTV-4 outbreaks have been reported in autumn 2016. This is the first report of the introduction in Corsica of a BTV strain previously spreading in eastern Europe.
Assuntos
Vírus Bluetongue/genética , Bluetongue/virologia , Doenças dos Bovinos/virologia , Genoma Viral/genética , Sequenciamento Completo do Genoma , Animais , Bluetongue/epidemiologia , Vírus Bluetongue/isolamento & purificação , Bovinos , Doenças dos Bovinos/epidemiologia , Surtos de Doenças/veterinária , Europa Oriental , França/epidemiologia , Ilhas , Itália , Filogenia , Sorogrupo , OvinosRESUMO
Bluetongue virus (BTV) hitherto consisted of 26 recognized serotypes, of which all except BTV-26 are primarily transmitted by certain species of Culicoides biting midges. Three variants of an additional 27th bluetongue virus serotype (BTV-27v01-v03) were recently detected in asymptomatic goats in Corsica, France, 2014-2015. Molecular characterization revealed genetic differences between the three variants. Therefore, in vivo characteristics were investigated by experimental infection of a total of 15 goats, 11 sheep and 4 cattle with any one of the three variants in separated animal trials. In goat trials, BTV-naïve animals of the same species were kept in a facility where direct contact was unhindered. Of the 15 inoculated goats, 13 and 14 animals were found positive for BTV-RNA and antibodies (Ab), respectively, until the end of the experiments. Surprisingly, BTV-Ab levels as measured with ELISA and neutralization test (SNT) were remarkably low in all seropositive goats. Virus isolation from whole-blood was possible at the peak of viremia until 49 dpi. Moreover, detection of BTV-27v02-RNA and Ab in one contact goat indicated that-similar to BTV-26-at least one of three BTV-27 variants may be transmitted by contact between goats. In the field, BTV-27 RNA can be detected up to 6 months in the whole-blood of BTV-27-infected Corsican goats. In contrast, BTV RNA was not detected in the blood of cattle or sheep. In addition, BTV-27 Abs were not detected in cattle and only a transient increase in Ab levels was observed in some sheep. None of the 30 animals showed obvious BT-like clinical signs. In summary, the phenotypes observed for BTV-27v01-v03 phenotypes correspond to a mixture of characteristics known for BTV-25 and 26.
Assuntos
Anticorpos Antivirais/sangue , Vírus Bluetongue/fisiologia , Bluetongue/transmissão , Doenças dos Bovinos/virologia , Ceratopogonidae/virologia , Doenças das Cabras/virologia , Animais , Doenças Assintomáticas , Bluetongue/virologia , Vírus Bluetongue/imunologia , Vírus Bluetongue/isolamento & purificação , Vírus Bluetongue/patogenicidade , Bovinos , Doenças dos Bovinos/transmissão , Ensaio de Imunoadsorção Enzimática/veterinária , França , Doenças das Cabras/transmissão , Cabras , Masculino , Testes de Neutralização/veterinária , Fenótipo , Sorogrupo , OvinosRESUMO
Bluetongue virus serotype 8 (BTV-8) re-emerged in Central France in August 2015. The viral strain identified is nearly identical to the one that circulated during the 2006/2009 massive outbreak throughout Europe. To address the question of an undetected BTV-8 circulation on the French territory, a serological study was conducted on young cattle along a transect of seven departments, three of them located in areas where the virus presence had been confirmed by RT-PCR by winter 2015/2016. Sera from 2,565 animals were collected during the winters preceding and following the re-emergence, with 414 animals being sampled in each of the two consecutive years. All samples were tested by competitive ELISA (IDVet) and, when enough serum was available, ELISA-positive samples were confirmed by seroneutralization tests. In areas with infected holdings, seropositive animals were found before the re-emergence (N = 14 of 511), significantly more on the following year (N = 17 of 257), and eight animals (N = 158) seroconverted over 2015. Seropositive animals were also detected as early as winter 2014/2015 in one department without known infected holdings (N = 12 of 150), and in winter 2015/2016 in three of them (N = 21 of 555), where seven animals (N = 154) seroconverted over 2015. These results suggest that BTV-8 may have spread at low levels before the re-emergence, even in areas considered virus-free. Unfortunately, whole blood from the seropositive animals was not available to definitely confirm the virus presence by RT-PCR.
Assuntos
Vírus Bluetongue/isolamento & purificação , Bluetongue/virologia , Doenças dos Bovinos/virologia , Doenças Transmissíveis Emergentes/veterinária , Surtos de Doenças/veterinária , Animais , Bluetongue/epidemiologia , Vírus Bluetongue/genética , Vírus Bluetongue/imunologia , Bovinos , Doenças dos Bovinos/epidemiologia , Doenças Transmissíveis Emergentes/epidemiologia , Ensaio de Imunoadsorção Enzimática/veterinária , França/epidemiologia , Reação em Cadeia da Polimerase em Tempo Real/veterinária , Estações do Ano , SorogrupoRESUMO
Undetected in Europe since 2010, bluetongue virus serotype 8 (BTV-8) re-emerged in August 2015 in Central France. To gain insight into the re-emergence on the French territory, we estimated the seroprevalence in cattle before the detection of BTV-8 in 2015, in areas differentially affected by the current outbreak. A retrospective survey based on the analysis of stored sera was thus conducted in the winter preceding the re-emergence in seven French departments including the one where the virus was first detected. A total of 10,066 sera were retrieved from animals sampled in 444 different herds in winter 2014/15. Between-herd seroprevalence revealed the presence of seropositive animals in almost all herds sampled (97.4%). The animal-level seroprevalence averaged at 44%, with a strong age pattern reflecting the cumulative exposure to both natural infection and to vaccination. A multivariable analysis allowed separating the respective effects of both exposures. A higher proportion of seropositivity risk was attributed to vaccination (67.4%) than to exposure to natural infection (24.2%). The evolution of seroprevalence induced by the two main risk factors in 74 mainland departments was reconstructed between the vaccination ban (2013) and the re-emergence (2015). We showed a striking decrease in seroprevalence with time after the vaccination ban, due to population renewal, which could have facilitated virus transmission leading to the current outbreak situation.
Assuntos
Vírus Bluetongue/imunologia , Bluetongue/epidemiologia , Doenças dos Bovinos/epidemiologia , Surtos de Doenças/veterinária , Animais , Bluetongue/prevenção & controle , Bluetongue/virologia , Bovinos , Doenças dos Bovinos/prevenção & controle , Doenças dos Bovinos/virologia , Europa (Continente) , França/epidemiologia , Estudos Retrospectivos , Fatores de Risco , Estações do Ano , Estudos Soroepidemiológicos , Sorogrupo , Ovinos , VacinaçãoRESUMO
At the end of August 2015, a ram located in central France (department of Allier) showed clinical signs suggestive of BTV (Bluetongue virus) infection. However, none of the other animals located in the herd showed any signs of the Bluetongue disease. Laboratory analyses identified the virus as BTV serotype 8. The viro and sero prevalence intraherd were 2.4% and 8.6% in sheep and 18.3% and 42.9% in cattle, respectively. Phylogenetic studies showed that the sequences of this strain are closely related to another BTV-8 strain that has circulated in France in 2006-2008. The origin of the outbreak is unclear but it may be assumed that the BTV-8 has probably circulated at very low prevalence (possibly in livestock or wildlife) since its first emergence in 2007-2008.
Assuntos
Vírus Bluetongue/classificação , Bluetongue/virologia , Doenças dos Bovinos/virologia , Doenças Transmissíveis Emergentes/veterinária , Animais , Bluetongue/epidemiologia , Bovinos , Doenças dos Bovinos/epidemiologia , Embrião de Galinha , Doenças Transmissíveis Emergentes/epidemiologia , Doenças Transmissíveis Emergentes/virologia , Cricetinae , Surtos de Doenças/veterinária , França/epidemiologia , Masculino , Camundongos , Camundongos Knockout , Filogenia , Prevalência , Sorogrupo , OvinosRESUMO
The Schmallenberg virus (SBV) has recently emerged in Europe, causing losses to the domestic livestock. A retrospective analysis of serodata was conducted in France for estimating seroprevalence of SBV among six wildlife species from 2011-2012 to 2013-2014, that is during the three vector seasons after the emergence of the SBV in France. Our objective was to quantify the exposure of wildlife to SBV and the potential protective effect of elevation such as previously observed for bluetongue. We also compared the spatiotemporal trends between domestic and wild animals at the level of the departments. We tested 2050 sera using competitive ELISA tests. Individual and population risk factors were further tested using general linear models among 1934 individuals. All populations but one exhibited positive results, seroprevalence up to 30% being observed for all species. The average seroprevalence did not differ between species but ranged from 0 to 90% according to the area and period, due to the dynamic pattern of infection. Seroprevalence was on average higher in the lowlands compared to areas located up to 800 m. Nevertheless, seroprevalence above 50% occurred in areas located up to 1500 m. Thus, contrary to what had been observed for bluetongue during the late 2000s in the same areas, SBV could spread to high altitudes and infect all the studied species. The spatial spread of SBV in wildlife did not fully match with SBV outbreaks reported in the domestic livestock. The mismatch was most obvious in mountainous areas where outbreaks in wildlife occurred on average one year after the peak of congenital cases in livestock. These results suggest a much larger spread and vector capacity for SBV than for bluetongue virus in natural areas. Potential consequences for wildlife dynamics are discussed.
Assuntos
Animais Selvagens/virologia , Infecções por Bunyaviridae/epidemiologia , Orthobunyavirus/isolamento & purificação , Animais , Bluetongue/epidemiologia , Surtos de Doenças , Ensaio de Imunoadsorção Enzimática , França/epidemiologia , Estudos Retrospectivos , Fatores de Risco , Estações do Ano , Estudos SoroepidemiológicosRESUMO
Bluetongue viruses (BTV) are arboviruses responsible for infections in ruminants. The confirmation of BTV infections is based on rapid serological tests such as enzyme-linked immunosorbent assays (ELISAs) using the BTV viral protein 7 (VP7) as antigen. The determination of the BTV serotype by serological analyses could be only performed by neutralization tests (VNT) which are time-consuming and require BSL3 facilities. VP2 protein is considered the major serotype-defining protein of BTV. To improve the serological characterization of BTV infections, the recombinant VP7 and BTV serotype 8 (BTV-8) VP2 were synthesized using insect cells expression system. The purified antigens were covalently bound to fluorescent beads and then assayed with 822 characterized ruminant sera from BTV vaccinations or infections in a duplex microsphere immunoassay (MIA). The revelation step of this serological duplex assay was performed with biotinylated antigens instead of antispecies conjugates to use it on different ruminant species. The results demonstrated that MIA detected the anti-VP7 antibodies with a high specificity as well as a competitive ELISA approved for BTV diagnosis, with a better efficiency for the early detection of the anti-VP7 antibodies. The VP2 MIA results showed that this technology is also an alternative to VNT for BTV diagnosis. Comparisons between the VP2 MIA and VNT results showed that VNT detects the anti-VP2 antibodies in an early stage and that the VP2 MIA is as specific as VNT. This novel immunoassay provides a platform for developing multiplex assays, in which the presence of antibodies against multiple BTV serotypes can be detected simultaneously.
Assuntos
Anticorpos Antivirais/sangue , Antígenos Virais/imunologia , Vírus Bluetongue/imunologia , Bluetongue/diagnóstico , Proteínas do Capsídeo/imunologia , Proteínas do Core Viral/imunologia , Animais , Biotinilação , Bluetongue/virologia , Vírus Bluetongue/isolamento & purificação , Ensaio de Imunoadsorção Enzimática/veterinária , Feminino , Imunoensaio/veterinária , Masculino , Microesferas , Proteínas Recombinantes , Ruminantes , Sensibilidade e Especificidade , Sorogrupo , OvinosRESUMO
Since 2000, French Corsica Island has been exposed to the emergence of three different BT virus (BTV) serotypes: serotype 2 in 2000 and 2001, serotype 4 in 2003 and serotype 16 in 2004. Between 2005 and August 2013, no outbreaks have been reported in the French Island. At the beginning of September 2013, sheep located in the south of the island showed clinical signs suggestive of BTV infection. Laboratory analyses identified the virus as BTV serotype 1. Phylogenetic studies showed that the sequences of this strain are closely related to the BTV-1 strain that was circulating in the Mediterranean basin and in Sardinia in 2012.
Assuntos
Vírus Bluetongue/isolamento & purificação , Bluetongue/epidemiologia , Surtos de Doenças/veterinária , Animais , Bluetongue/virologia , Vírus Bluetongue/classificação , Vírus Bluetongue/genética , Vírus Bluetongue/imunologia , França/epidemiologia , Ilhas , Filogenia , Vigilância de Evento Sentinela/veterinária , Sorogrupo , OvinosRESUMO
Recently, a contamination incident was described in which the challenge inoculum used in a bluetongue virus serotype 8 (BTV-8) vaccination trial was contaminated with a BTV-11 virus that was closely related to the Belgian BTV-11 virus from 2008. This study reports the first complete genome sequences of four BTV-11 viruses: the BTV-11 contaminant, BTV-11 reference strain, BTV-11 vaccine strain and a recently isolated BTV-11 field strain from Martinique. Full-genome analysis showed that these viruses belong to serotype 11/nucleotype A and cluster together with other western topotype bluetongue viruses. Detailed comparisons of the genomes further indicated that the contaminant was derived from the BTV-11 reference strain, as they were distinguished by a single synonymous nucleotide substitution. The previously reported partial sequence of genome segment 2 of the Belgian BTV-11 was found to be identical to that of the BTV-11 vaccine strain, indicating that it most likely was the BTV-11 vaccine strain. These findings also suggest that the BTV-11 contaminant and the Belgian BTV-11 are not the same viruses. Finally, comparison of the reference and vaccine strain did not allow determining the amino acid substitutions that contribute to the attenuated phenotype.
Assuntos
Vírus Bluetongue/genética , Bluetongue/prevenção & controle , Genoma Viral/genética , Vacinas Virais , Animais , Sequência de Bases , Vírus Bluetongue/classificação , Vírus Bluetongue/imunologia , Vírus Bluetongue/isolamento & purificação , Europa (Continente) , Dados de Sequência Molecular , Filogenia , Sorogrupo , Ovinos , Vacinação/veterinária , Vacinas Virais/administração & dosagemRESUMO
By using a novel consensus approach, we have previously managed to generate a fully synthetic phytase, consensus phytase-1, that was 15-26 degrees C more thermostable than the parent fungal phytases used in its design (Lehmann et al., 2000). We now sought to use the backbone of consensus phytase-1 and to modify its catalytic properties. This was done by replacing a considerable part of the active site (i.e., all the divergent residues) with the corresponding residues of Aspergillus niger NRRL 3135 phytase, which displays pronounced differences in specific activity, substrate specificity, and pH-activity profile. For the new protein termed consensus phytase-7, a major - although not complete - shift in catalytic properties was observed, demonstrating that rational transfer of favorable catalytic properties from one phytase to another is possible by using this approach. Although the exchange of the active site was associated with a 7.6 degrees C decrease in unfolding temperature (Tm) as measured by differential scanning calorimetry, consensus phytase-7 still was >7 degrees C more thermostable than all wild-type ascomycete phytases known to date. Thus, combination of the consensus approach with the selection of a "preferred" active site allows the design of a thermostabilized variant of an enzyme family of interest that (most closely) matches the most favorable catalytic properties found among its family members.
Assuntos
6-Fitase/química , 6-Fitase/metabolismo , 6-Fitase/genética , Sequência de Aminoácidos , Substituição de Aminoácidos , Aspergillus niger/enzimologia , Aspergillus niger/genética , Sítios de Ligação , Sequência Consenso , Primers do DNA , Estabilidade Enzimática , Escherichia coli , Concentração de Íons de Hidrogênio , Cinética , Modelos Moleculares , Dados de Sequência Molecular , Conformação Proteica , Proteínas Recombinantes/química , Proteínas Recombinantes/metabolismo , Alinhamento de Sequência , Homologia de Sequência de Aminoácidos , TermodinâmicaRESUMO
Having previously shown that orogastric stimulation with carbohydrates or sweeteners triggers an increase in metabolic rate and in respiratory quotient, we investigated the possibility that the umami taste of monosodium glutamate (MSG) could act similarly on metabolic responses to protein ingestion. Monosodium glutamate solutions (0.01 and 0.15 M) or vehicle were infused via an intraoral tube during a standardized meal of chow taken in a metabolic device linked to a computer capable of instantaneously measuring RQ and background (resting) metabolic rate in the freely behaving rat. Monosodium glutamate added to the food resulted in a rapid enhancement of metabolic rate that lasted about 30 min, i.e., the period of the anticipatory fraction of thermogenesis. The RQ also switched towards figures indicative of protein utilization. Monosodium glutamate is ineffective when administered independently of meal taking. Taken together these data indicate that the umami taste of MSG exerts an enhancing and specific action on metabolism that obeys the rules of anticipatory reflexes in the sense that both the metabolic rate and substrate utilization adapt from the very first announcement of ingestion of an extra load of protein.
Assuntos
Temperatura Corporal/efeitos dos fármacos , Alimentos , Respiração/efeitos dos fármacos , Glutamato de Sódio/farmacologia , Paladar/efeitos dos fármacos , Animais , Calorimetria , Dieta , Masculino , Ratos , Ratos WistarRESUMO
Umami taste appears to signal, at the gustatory level, the intake of proteins, therefore the working hypothesis was: does umami taste of a monosodium glutamate (MSG) solution elicit changes in both glucagon and insulin release, similar to those elicited by amino acids, and consequently, changes in plasma glucose and in overall cellular metabolism? In a first experiment, rats were equipped with indwelling jugular and oral catheter and serial samplings were made in the free moving, undisturbed rat before and after an oral or IV infusion of MSG (0.05 M). None of the plasma parameters showed any significant response. In a second experiment, energy expenditure was monitored by means of an original computer-based calorimeter capable of calculating, besides the classical parameters, resting metabolism in a moving animal (designated by background metabolism). The addition of MSG to a low calorie, low-protein meal did not modify background metabolism or respiratory quotient. Therefore MSG ingestion does not by itself affect plasma levels of hormones of glucose and protein metabolism, total metabolism rate, or nutrient utilization. However, examination of individual data and those from a pilot experiment for future work suggests that MSG becomes an efficient metabolic effector if added to a caloric diet, and so enhances proper thermogenesis of macronutrients.
Assuntos
Metabolismo Energético/fisiologia , Preferências Alimentares/fisiologia , Glucagon/fisiologia , Insulina/fisiologia , Glutamato de Sódio , Paladar/fisiologia , Animais , Glicemia/metabolismo , Regulação da Temperatura Corporal/efeitos dos fármacos , Regulação da Temperatura Corporal/fisiologia , Metabolismo Energético/efeitos dos fármacos , Preferências Alimentares/efeitos dos fármacos , Masculino , Atividade Motora/efeitos dos fármacos , Atividade Motora/fisiologia , Ratos , Ratos Endogâmicos , Glutamato de Sódio/farmacologia , Paladar/efeitos dos fármacosRESUMO
Sixteen sheep and 18 cattle were followed up during 1 year to estimate the duration of immunity induced by inactivated bluetongue virus serotype 8 (BTV-8) vaccines (sheep and cattle) and a bluetongue virus serotype 1 (BTV-1) vaccine (cattle) under field conditions using cELISA and seroneutralization test (SNT). Four sheep never seroconverted. Those that seroconverted were all seronegative by BTV-8 SNT at the date of last sampling [378 days post-vaccination (dpv)]. Eight sheep were still positive by competitive ELISA (cELISA) 378 dpv. All the cattle seroconverted. At the end of the study, eight and 11 cattle were still positive by BTV-8 SNT and cELISA, respectively (335 dpv); and nine were still positive by BTV-1 SNT (301 dpv).
Assuntos
Vírus Bluetongue/imunologia , Bluetongue/prevenção & controle , Doenças dos Bovinos/prevenção & controle , Vacinas Virais/imunologia , Animais , Anticorpos Antivirais/sangue , Anticorpos Antivirais/imunologia , Bovinos , Ensaio de Imunoadsorção Enzimática/veterinária , Sorotipagem , Ovinos , Vacinação/veterinária , Vacinas de Produtos InativadosRESUMO
During the incursion of bluetongue virus (BTV) serotype 8 in Europe, an increase in the number of abortions in ruminants was observed. Transplacental transmission of BTV-8 in cattle and sheep, with subsequent foetal infection, is a feature of this specific bluetongue serotype. In this study, BTV-8 ability to cross the placental barrier at the beginning of the second third of pregnancy and at the end of pregnancy was investigated in goats in two separate experiments. In the first experiment, nine goats were experimentally infected with BTV-8 at 61 days of pregnancy. Foetuses were collected 21 dpi. BTV-8 was evidenced by real time RT-PCR and by viral isolation using blood from the umbilical cord and the spleens of 3 out of the 13 foetuses. All dams were viraemic (viral isolation) at the moment of sampling of the foetuses. Significant macroscopic or histological lesions could not be observed in foetuses or in their infected dams (notably at the placenta level). In the second experiment, 10 goats were infected with BTV-8 at 135 days of pregnancy. Kids were born by caesarean section at the programmed day of birth (15 dpi). BTV-8 could not be detected by rt-RT-PCR in blood or spleen samples from the kids. This study showed for the first time that BTV-8 transplacental transmission can occur in goats that have been infected at 61 days of pregnancy, with infectious virus recovered from the caprine foetuses. The observed transmission rate was quite high (33%) at this stage of pregnancy. However, it was not possible to demonstrate the existence of BTV-8 transplacental transmission when infection occurred at the end of the goat pregnancy.
Assuntos
Aborto Animal/virologia , Vírus Bluetongue/fisiologia , Bluetongue/transmissão , Doenças das Cabras/transmissão , Transmissão Vertical de Doenças Infecciosas/veterinária , Placenta/virologia , Complicações Infecciosas na Gravidez/veterinária , Aborto Animal/patologia , Animais , Bluetongue/patologia , Bluetongue/virologia , Vírus Bluetongue/isolamento & purificação , Feminino , Feto/patologia , Feto/virologia , Doenças das Cabras/patologia , Doenças das Cabras/virologia , Cabras , Masculino , Placenta/patologia , Gravidez , Complicações Infecciosas na Gravidez/patologia , Complicações Infecciosas na Gravidez/virologiaRESUMO
Bluetongue serotype 8 has become a major animal health issue in the European Union and the European member States have agreed on a vaccination strategy, which involves only inactivated vaccines. In this study, the efficacy of two inactivated vaccines against bluetongue virus serotype 8 (BTV-8) used in Europe since 2008, BTVPUR ALSAP(®) 8 (MERIAL) and BOVILIS(®) BTV8 (Intervet/SP-AH), was evaluated in goats immunized and challenged with BTV-8 field isolates under experimental conditions. Serological, virological and clinical examinations were conducted before and after challenge. Three groups of 10 goats each (groups A, B and C) were randomly constituted and 2 groups (A and C) were subcutaneously vaccinated twice with one dose of the two commercial vaccines BTVPUR ALSAP 8 (group A) or BOVILIS BTV8 (group C) respectively. Animals of the groups A, C and B (B: controls) were challenged with a virulent inoculum containing BTV-8. During the experiment, it was found out that the BTV-8 challenge inoculum was contaminated with another BTV serotype. However, results demonstrated that vaccination of goats with two injections of BTVPUR ALSAP 8 or BOVILIS BTV8 provided a significant clinical protection against a BTV-8 challenge and completely prevented BTV-8 viraemia in all vaccinated animals. Qualitative data showed no difference in the kinetics and levels of the humoral response induced by these two inactivated vaccines.